Blog

If you’re managing an immune condition, you may have heard about SCIg (subcutaneous immunoglobulin) and IVIG (intravenous immunoglobulin).  Both SCIg and IVIG therapy provide essential immune support, but they work in different ways. Knowing which is the right option can seem complicated, but you don’t have to navigate it alone. No matter who you are, it’s important to find a treatment that fits your lifestyle, comfort level, and health goals.  By learning more about the differences between SCIg and IVIG, you’ll be better equipped to make an informed decision alongside your healthcare team—one that supports both your well-being and your daily routine.  What Is Immunoglobulin Therapy? Immunoglobulin replacement therapy gives

When you’re managing a complex health condition, you may have questions about your treatment options.  Two therapies you might hear about are IVIG (intravenous immunoglobulin) and plasmapheresis. Both can play an important role in supporting your immune system, but they work in different ways. Everyone’s treatment journey is different, and what you need will depend on your condition as well as a few other factors. What matters most is that you feel supported, informed, and involved in your care.  What Is IVIG? IVIG, or intravenous immunoglobulin, is a therapy that gives your immune system a helpful boost.  IG (immunoglobulin) therapy is made from antibodies—special proteins that help your body fight

Your immune system is designed to protect you, but sometimes it misfires and attacks healthy cells, leading to autoimmune conditions.  Intravenous Immunoglobulin (IVIG) helps by delivering much-needed antibodies through an IV, helping to calm the immune response and reduce inflammation in your body.  IVIG treatment can help reduce infections, offering relief to many who are struggling. Whether used alone or with other therapies, IVIG can be an important part of managing autoimmune diseases. Getting to Know IVIG If you’re managing an autoimmune condition, you may have heard of IVIG—but what exactly does it do?  If you’re wondering whether IVIG might be right for you, talking with a healthcare provider is

Subcutaneous immunoglobulin (SCIg) therapy might seem complex at first, but once you get the basics, it’s actually pretty straightforward.  SCIg provides consistent immune support without the need for long clinic visits. Life can get busy and overwhelming, and SCIg provides an option that allows treatments to be done at home—helping to ease stress and save time. The treatment works simply by boosting antibody levels, which helps strengthen the immune system, especially for those who have trouble fighting infections. Learning more about SCIG therapy can make it easier to manage your health and can simplify your routine.  What Is SCIg? SCIg, or subcutaneous immunoglobulin therapy, delivers important antibodies just under the

IVIG, or Intravenous Immunoglobulin (derived from IG), is a remarkable therapy made possible by the generosity of thousands of plasma donors.  IG (immunoglobulin) therapy starts with the liquid part of the blood—plasma—collected from healthy individuals. From there, medical teams carefully extract immunoglobulins, or antibodies, which are then purified and prepared to help support or regulate the immune system. This process transforms donated plasma into a powerful therapy for people with immune deficiencies and autoimmune conditions. Understanding how IVIG is made can bring real reassurance and peace of mind to anyone considering treatment. Every step—from plasma collection to purification and rigorous safety testing—is handled with precision and care.  It’s not just

If you’ve just started IVIG therapy, you might be wondering how to tell if it’s making a difference. It’s a common concern—waiting for results can feel frustrating, especially when managing a neurological or autoimmune condition, or addressing immunodeficiencies.  Since everyone responds differently, there’s no single timeline for improvement. That said, there are signs that IVIG (intravenous immunoglobulin) may be working for you. You might notice fewer infections, milder flare-ups, or even small boosts in energy. Some people feel a difference within weeks, while for others, it takes longer. Tracking your symptoms and how you’re feeling day to day can provide clarity and reassurance. Understanding IVIG At first glance, the idea

By Janelle Torres, Director, Corporate Accounts, California Specialty Pharmacy As healthcare continues its shift away from fee-for-service and towards value-based or global payment models, hospitals are looking for ways to improve patient outcomes while simultaneously reducing costs. One promising area that works well with this new payment paradigm is the transitioning of infusion therapy patients away from the hospital setting into the patient’s home or an ambulatory infusion suite (AIS). Hospitals, while no doubt equipped with skilled healthcare professionals and valuable cutting-edge technologies, can be among the most expensive sites in which to receive care. The cost of hospitalization, including room charges, staffing, supplies, and other overhead, can significantly increase

Few stakeholders in the industry would doubt the impact personalized care can have on patients’ health. We know that one-size-fits-all treatments and care plans are no longer the standard, especially for complex or chronic conditions such as multiple sclerosis, autoimmune disorders, and cancer. Different patients may respond differently to the same treatment regimen based on a multitude of factors, from pharmacogenomics to mental health to social determinants of health (including varying levels of family and community support, health literacy, income level, and more).  For example, one meta-analysis of 19 studies involving a total of 10,856 participants with health conditions including diabetes, mental health, heart failure, renal disease, asthma, and other

Medication adherence continues to be a serious public health issue in the US, with about 67 percent of patients being non-adherent with prescribed medications.1 Non-adherence accounts for about 50 percent of treatment failures, 125,000 deaths each year, and increased healthcare costs, especially when it comes to the management of chronic conditions.2 Payors, providers, and pharmacists can work collaboratively to ensure patients adhere to timing, dosage, and frequency for prescribed medications.  Factors Impacting Non-Adherence The first step in improving adherence is understanding and acknowledging the contributing factors. Common reasons patients do not adhere to prescribed medication regimens include: Affordability/insurance coverage: One in four Americans taking prescription medications cite affordability as a

Consistently following your multiple sclerosis (MS) treatment plan, along with a holistic approach to your health, can make a significant impact on your quality of life. MS is a chronic neurological condition that requires consistent care. Taking medication regularly as prescribed can help delay disease progression and decrease the risk of relapse. What Happens When You Skip or Stop Your MS Medication?  Relapses, which are episodic flare-ups of symptoms, can be common with certain kinds of MS. To reduce the frequency and severity of MS relapses, disease-modifying therapies are essential. Medications help manage symptoms like fatigue, muscle weakness, and cognitive issues. Skipping doses or stopping treatment can lead to a